Preoperative Frailty and Malnutrition in Surgical Oncology Patients Predicts Higher Postoperative Adverse Events and Worse Survival: Results of a Blinded, Prospective Trial.
Journal
Annals of surgical oncology
ISSN: 1534-4681
Titre abrégé: Ann Surg Oncol
Pays: United States
ID NLM: 9420840
Informations de publication
Date de publication:
21 Dec 2023
21 Dec 2023
Historique:
received:
15
08
2023
accepted:
16
11
2023
medline:
21
12
2023
pubmed:
21
12
2023
entrez:
21
12
2023
Statut:
aheadofprint
Résumé
Frailty, a multidimensional state leading to reduced physiologic reserve, is associated with worse postoperative outcomes. Despite the availability of various frailty tools, surgeons often make subjective assessments of patients' ability to tolerate surgery. The Risk Analysis Index (RAI) is a validated preoperative frailty assessment tool that has not been studied in cancer patients with plans for curative-intent surgery. In this prospective, surgeon-blinded study, patients who had abdominal malignancy with plans for resection underwent preoperative frailty assessment with the RAI and nutrition assessment by measurement of albumin, prealbumin, and C-reactive protein (CRP). Postoperative outcomes and survival were assessed. The study included 220 patients, 158 (72%) of whom were considered frail (RAI ≥21). Frail patients were more likely to be readmitted within 30 and 90 days, (16% vs. 3% [P = 0.006] and 16% vs. 5% [P = 0.025], respectively). Patients with abnormal CRP, prealbumin, and albumin experienced higher rates of unplanned intensive care unit admission (CRP [27% vs. 8%; P < 0.001], albumin [30% vs. 10%; P < 0.001], prealbumin [29% vs. 9%; P < 0.001]) and increased postoperative mortality at 90 and 180 days. Survival was similar for frail and non-frail patients. In the multivariate analysis, frailty remained an independent risk factor for readmission (hazard ratio, 5.58; 95% confidence interval, 1.39-22.15; P = 0.015). In the post hoc analysis using the pre-cancer RAI score, the postoperative outcomes did not differ between the frail and non-frail patients. In conjunction with preoperative markers of nutrition, the RAI may be used to identify patients who may benefit from additional preoperative risk stratification and increased postoperative follow-up evaluation.
Sections du résumé
BACKGROUND
BACKGROUND
Frailty, a multidimensional state leading to reduced physiologic reserve, is associated with worse postoperative outcomes. Despite the availability of various frailty tools, surgeons often make subjective assessments of patients' ability to tolerate surgery. The Risk Analysis Index (RAI) is a validated preoperative frailty assessment tool that has not been studied in cancer patients with plans for curative-intent surgery.
METHODS
METHODS
In this prospective, surgeon-blinded study, patients who had abdominal malignancy with plans for resection underwent preoperative frailty assessment with the RAI and nutrition assessment by measurement of albumin, prealbumin, and C-reactive protein (CRP). Postoperative outcomes and survival were assessed.
RESULTS
RESULTS
The study included 220 patients, 158 (72%) of whom were considered frail (RAI ≥21). Frail patients were more likely to be readmitted within 30 and 90 days, (16% vs. 3% [P = 0.006] and 16% vs. 5% [P = 0.025], respectively). Patients with abnormal CRP, prealbumin, and albumin experienced higher rates of unplanned intensive care unit admission (CRP [27% vs. 8%; P < 0.001], albumin [30% vs. 10%; P < 0.001], prealbumin [29% vs. 9%; P < 0.001]) and increased postoperative mortality at 90 and 180 days. Survival was similar for frail and non-frail patients. In the multivariate analysis, frailty remained an independent risk factor for readmission (hazard ratio, 5.58; 95% confidence interval, 1.39-22.15; P = 0.015). In the post hoc analysis using the pre-cancer RAI score, the postoperative outcomes did not differ between the frail and non-frail patients.
CONCLUSION
CONCLUSIONS
In conjunction with preoperative markers of nutrition, the RAI may be used to identify patients who may benefit from additional preoperative risk stratification and increased postoperative follow-up evaluation.
Identifiants
pubmed: 38127214
doi: 10.1245/s10434-023-14693-9
pii: 10.1245/s10434-023-14693-9
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. Society of Surgical Oncology.
Références
Lin HS, Watts JN, Peel NM, Hubbard RE. Frailty and postoperative outcomes in older surgical patients: a systematic review. BMC Geriatr. 2016;16:157.
doi: 10.1186/s12877-016-0329-8
pubmed: 27580947
pmcid: 5007853
Panayi AC, Orkaby AR, Sakthivel D, et al. Impact of frailty on outcomes in surgical patients: a systematic review and meta-analysis. Am J Surg. 2019;218:393–400.
doi: 10.1016/j.amjsurg.2018.11.020
pubmed: 30509455
Stevens L, Pathak S, Nunes QM, et al. Prognostic significance of preoperative C-reactive protein and the neutrophil-lymphocyte ratio in resectable pancreatic cancer: a systematic review. HPB. 2015;17:285–91.
doi: 10.1111/hpb.12355
pubmed: 25431369
Gupta A, Gupta E, Hilsden R, et al. Preoperative malnutrition in patients with colorectal cancer. Can J Surg. 2021;64:E621–9.
doi: 10.1503/cjs.016820
pubmed: 34824150
pmcid: 8628841
Peng J, Zhang R, Zhao Y, et al. Prognostic value of preoperative prognostic nutritional index and its associations with systemic inflammatory response markers in patients with stage III colon cancer. Chin J Cancer. 2017;36:96.
doi: 10.1186/s40880-017-0260-1
pubmed: 29268783
pmcid: 5740941
Simon R. Complications after pancreaticoduodenectomy. Surg Clin North Am. 2021;101:865–74.
doi: 10.1016/j.suc.2021.06.011
pubmed: 34537148
van Stein RM, Aalbers AGJ, Sonke GS, van Driel WJ. Hyperthermic Intraperitoneal chemotherapy for ovarian and colorectal cancer: a review. JAMA Oncol. 2021;7:1231–8.
doi: 10.1001/jamaoncol.2021.0580
pubmed: 33956063
Nakazawa N, Sohda M, Yamaguchi A, et al. Preoperative risk factors and prognostic impact of postoperative complications associated with total gastrectomy. Digestion. 2022;103:397–403.
doi: 10.1159/000525356
pubmed: 35724642
Russell MC. Complications following hepatectomy. Surg Oncol Clin North Am. 2015;24:73–96.
doi: 10.1016/j.soc.2014.09.008
Hall DE, Arya S, Schmid KK, et al. Development and initial validation of the risk analysis index for measuring frailty in surgical populations. JAMA Surg. 2017;152:175–82.
doi: 10.1001/jamasurg.2016.4202
pubmed: 27893030
pmcid: 7140150
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.
doi: 10.1097/01.sla.0000133083.54934.ae
pubmed: 15273542
pmcid: 1360123
van der Windt DJ, Bou-Samra P, Dadashzadeh ER, Chen X, Varley PR, Tsung A. Preoperative risk analysis index for frailty predicts short-term outcomes after hepatopancreatobiliary surgery. HPB. 2018;20:1181–8.
doi: 10.1016/j.hpb.2018.05.016
pubmed: 30005992
Mahmooth Z, Carpenter E, Lin E, et al. Frailty assessment in the acute care surgery population: the agreement and predictive value on length of stay and re-admission of 3 different instruments in a prospective cohort. Am J Surg. 2020;220:1058–63.
doi: 10.1016/j.amjsurg.2020.03.026
pubmed: 32312476
Shah R, Attwood K, Arya S, et al. Association of frailty with failure to rescue after low-risk and high-risk inpatient surgery. JAMA Surg. 2018;153:e180214.
doi: 10.1001/jamasurg.2018.0214
pubmed: 29562073
pmcid: 5875343
Lu J, Xu BB, Xue Z, et al. Perioperative CRP: a novel inflammation-based classification in gastric cancer for recurrence and chemotherapy benefit. Cancer Med. 2021;10:34–44.
doi: 10.1002/cam4.3514
pubmed: 33270989
Bert M, Devilliers H, Orry D, Rat P, Facy O, Ortega-Deballon P. Preoperative inflammation is an independent factor of worse prognosis after colorectal cancer surgery. J Visc Surg. 2021;158:305–11.
doi: 10.1016/j.jviscsurg.2020.08.001
pubmed: 33446466
Li JD, Xu XF, Han J, et al. Preoperative prealbumin level as an independent predictor of long-term prognosis after liver resection for hepatocellular carcinoma: a multi-institutional study. HPB. 2019;21:157–66.
doi: 10.1016/j.hpb.2018.06.1803
pubmed: 30082212
Zheng BH, Yang LX, Sun QM, et al. A new preoperative prognostic system combining CRP and CA199 for patients with intrahepatic cholangiocarcinoma. Clin Transl Gastroenterol. 2017;8:e118.
doi: 10.1038/ctg.2017.45
pubmed: 28981082
pmcid: 5666116
Moghadamyeghaneh Z, Hwang G, Hanna MH, et al. Even modest hypoalbuminemia affects outcomes of colorectal surgery patients. Am J Surg. 2015;210:276–84.
doi: 10.1016/j.amjsurg.2014.12.038
pubmed: 25892597
Gupta D, Lis CG. Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J. 2010;9:69.
doi: 10.1186/1475-2891-9-69
pubmed: 21176210
pmcid: 3019132
Hu WH, Cajas-Monson LC, Eisenstein S, Parry L, Cosman B, Ramamoorthy S. Preoperative malnutrition assessments as predictors of postoperative mortality and morbidity in colorectal cancer: an analysis of ACS-NSQIP. Nutr J. 2015;14:91.
doi: 10.1186/s12937-015-0081-5
pubmed: 26345703
pmcid: 4561437
Zhou J, Hiki N, Mine S, et al. Role of prealbumin as a powerful and simple index for predicting postoperative complications after gastric cancer surgery. Ann Surg Oncol. 2017;24:510–7.
doi: 10.1245/s10434-016-5548-x
pubmed: 27638673
Estock JL, Schlegel C, Shinall MC, et al. Interpreting the risk analysis index of frailty in the context of surgical oncology. J Surg Oncol. 2023;127:1062–70.
doi: 10.1002/jso.27218
pubmed: 36881022
Shinall MC Jr, Arya S, Youk A, et al. Association of preoperative patient frailty and operative stress with postoperative mortality. JAMA Surg. 2020;155:e194620.
doi: 10.1001/jamasurg.2019.4620
pubmed: 31721994
Varley PR, Buchanan D, Bilderback A, et al. Association of routine preoperative frailty assessment with 1-year postoperative mortality. JAMA Surg. 2023;158:475–83.
doi: 10.1001/jamasurg.2022.8341
pubmed: 36811872
Mareschal J, Hemmer A, Douissard J, et al. Surgical prehabilitation in patients with gastrointestinal cancers: impact of unimodal and multimodal programs on postoperative outcomes and prospects for new therapeutic strategies: a systematic review. Cancers. 2023. https://doi.org/10.3390/cancers15061881 .
doi: 10.3390/cancers15061881
pubmed: 36980767
pmcid: 10047365
Trépanier M, Minnella EM, Paradis T, et al. Improved disease-free survival after prehabilitation for colorectal cancer surgery. Ann Surg. 2019;270:493–501.
doi: 10.1097/SLA.0000000000003465
pubmed: 31318793
Molenaar CJ, van Rooijen SJ, Fokkenrood HJ, Roumen RM, Janssen L, Slooter GD. Prehabilitation versus no prehabilitation to improve functional capacity, reduce postoperative complications, and improve quality of life in colorectal cancer surgery. Cochrane Database Syst Rev. 2022;5:CD013259.
pubmed: 35588252